Expression of CD274 (PD-L1) is associated with unfavourable recurrent mutations in AML

Br J Haematol. 2018 Dec;183(5):822-825. doi: 10.1111/bjh.15040. Epub 2017 Dec 19.

Authors

Malgorzata Zajac¹, Joanna Zaleska¹, Anna Dolnik², Lars Bullinger², Krzysztof Giannopoulos^{1

3}

Affiliations

¹ Department of Experimental Haemato-oncology, Medical University of Lublin, Lublin, Poland.
² Department of Internal Medicine III, University of Ulm, Ulm, Germany.
³ Department of Haematology, St. John's Cancer Centre, Lublin, Poland.

PMID: 29265177
DOI: 10.1111/bjh.15040

No abstract available

Keywords: AML; CD274; MIR34A; TP53; PD-L1.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

B7-H1 Antigen / metabolism*
Genes, p53 / genetics
Humans
Immunity, Cellular / genetics
Leukemia, Myeloid, Acute / genetics*
Leukemia, Myeloid, Acute / immunology
MicroRNAs / metabolism
Mutation / genetics*
Recurrence
Risk Factors

Substances

B7-H1 Antigen
CD274 protein, human
MIRN34 microRNA, human
MicroRNAs